📊 ADTX Key Takeaways
Is Aditxt, Inc. (ADTX) a Good Investment?
Aditxt is in severe financial distress with negative stockholders' equity of -$7.7M, liabilities exceeding assets by $8.9M, and a critical liquidity crisis evidenced by a current ratio of 0.02x with only $163K in cash. The company is burning cash at an alarming rate (-$16.4M operating cash flow) while revenue has collapsed 79% YoY to just $2.8K, indicating complete business deterioration and imminent solvency risk.
Aditxt’s fundamentals are severely impaired: revenue is negligible, margins are deeply negative, and the business is consuming far more cash than it generates. With only $163K of cash, a 0.02x current ratio, and negative stockholders’ equity, the company’s near-term financial health appears highly stressed and its growth quality is extremely weak.
Why Buy Aditxt, Inc. Stock? ADTX Key Strengths
- Minimal capital expenditure requirements ($14.4K) reduces near-term cash drain
- Gross margin of 10.8% on remaining revenue shows some contribution on sales
- Single Form 4 filing suggests limited insider selling pressure in past 90 days
- Net loss improved year over year, indicating losses narrowed from the prior period
- Capital expenditure is minimal, so cash burn is not being driven by heavy fixed-asset spending
- The company still retains an asset base of $11.8M that could support ongoing operations or restructuring efforts
ADTX Stock Risks: Aditxt, Inc. Investment Risks
- Negative stockholders' equity represents technical insolvency and shareholder capital destruction
- Extreme liquidity crisis: current ratio of 0.02x indicates inability to meet short-term obligations
- Revenue collapse of 79% YoY and only $2.8K in latest period suggests business has essentially ceased operations
- Operating cash burn of -$16.4M with only $163K cash on hand creates immediate bankruptcy risk
- $20.7M in total liabilities with negative equity creates unsustainable debt burden
- Net loss of -$37.0M despite minimal revenue indicates severe operational distress
- Liquidity is critically weak, with just $163K of cash and a 0.02x current ratio
- Revenue base is extremely small and declined 79.2% year over year, raising major questions about commercial viability
- Negative equity and large operating and free cash flow losses indicate a highly fragile balance sheet and funding dependence
Key Metrics to Watch
- Cash balance and runway to insolvency (months)
- Revenue stabilization or further decline trends
- Debt restructuring or refinancing announcements
- Going concern disclosures in SEC filings
- Insider transactions and management changes
- Quarterly revenue growth and gross margin improvement
- Cash balance relative to operating cash burn and current liabilities
Aditxt, Inc. (ADTX) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
ADTX Profit Margin, ROE & Profitability Analysis
ADTX vs Healthcare Sector: How Aditxt, Inc. Compares
How Aditxt, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Aditxt, Inc. Stock Overvalued? ADTX Valuation Analysis 2026
Based on fundamental analysis, Aditxt, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Aditxt, Inc. Balance Sheet: ADTX Debt, Cash & Liquidity
ADTX Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Aditxt, Inc.'s revenue has grown significantly by 28% over the 5-year period, indicating strong business expansion. The most recent EPS of $-22,147,415.22 indicates the company is currently unprofitable.
ADTX Revenue Growth, EPS Growth & YoY Performance
ADTX Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $748 | -$12.8M | $-548.78 |
| Q2 2025 | $1.0K | -$7.3M | $-3.45 |
| Q1 2025 | $1.0K | -$5.7M | $-8.12 |
| Q3 2024 | $6.9K | -$9.9M | $-111.07 |
| Q2 2024 | $44.3K | -$5.7M | $-4.19 |
| Q1 2024 | $79.7K | -$6.0M | $-9.21 |
| Q3 2023 | $124.5K | -$5.7M | $-47.95 |
| Q2 2023 | $214.7K | -$5.7M | $-0.93 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Aditxt, Inc. Dividends, Buybacks & Capital Allocation
ADTX SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Aditxt, Inc. (CIK: 0001726711)
📋 Recent SEC Filings
❓ Frequently Asked Questions about ADTX
What is the AI rating for ADTX?
Aditxt, Inc. (ADTX) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 96% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are ADTX's key strengths?
Claude: Minimal capital expenditure requirements ($14.4K) reduces near-term cash drain. Gross margin of 10.8% on remaining revenue shows some contribution on sales. ChatGPT: Net loss improved year over year, indicating losses narrowed from the prior period. Capital expenditure is minimal, so cash burn is not being driven by heavy fixed-asset spending.
What are the risks of investing in ADTX?
Claude: Negative stockholders' equity represents technical insolvency and shareholder capital destruction. Extreme liquidity crisis: current ratio of 0.02x indicates inability to meet short-term obligations. ChatGPT: Liquidity is critically weak, with just $163K of cash and a 0.02x current ratio. Revenue base is extremely small and declined 79.2% year over year, raising major questions about commercial viability.
What is ADTX's revenue and growth?
Aditxt, Inc. reported revenue of $2.8K.
Does ADTX pay dividends?
Aditxt, Inc. does not currently pay dividends.
Where can I find ADTX SEC filings?
Official SEC filings for Aditxt, Inc. (CIK: 0001726711) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is ADTX's EPS?
Aditxt, Inc. has a diluted EPS of $-1,605.17.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is ADTX a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Aditxt, Inc. has a STRONG SELL rating with 96% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is ADTX stock overvalued or undervalued?
Valuation metrics for ADTX: ROE of N/A (sector avg: 15%), net margin of -1,336,192.1% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy ADTX stock in 2026?
Our dual AI analysis gives Aditxt, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is ADTX's free cash flow?
Aditxt, Inc.'s operating cash flow is $-16.4M, with capital expenditures of $14.4K. FCF margin is -594,118.9%.
How does ADTX compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -1,336,192.1% (avg: 12%), ROE N/A (avg: 15%), current ratio 0.02 (avg: 2).